Men's Health Boston

Men's Health Boston, established in 1999 by Dr. Abraham Morgentaler, is a pioneering healthcare venture dedicated to addressing the unique medical needs of men. The clinic focuses on various aspects, including sexuality, fertility, urination, hormone balance, and prostate health, while also considering psychological well-being. Dr. Morgentaler's groundbreaking research on testosterone, erectile dysfunction, prostate disease, and infertility has significantly influenced the field of men’s health.

Operating as a four-physician practice with a strong emphasis on clinical research, Men's Health Boston stands as a leader in men’s sexual health. The physicians are renowned for their contributions to national and international scientific conferences, providing expert insights at FDA meetings, training future specialists, and publishing influential research. They have also played a pivotal role in introducing innovative treatments such as testosterone therapy for men with prostate cancer, implantable testosterone pellets, and collagenase injections for Peyronie’s disease.

In November 2014, Men’s Health Boston relocated to a state-of-the-art clinical space at Chestnut Hill Square in Chestnut Hill, Massachusetts, enabling the practice to extend its world-class expertise and research to a broader patient base.

This venture in the healthcare industry has the potential to attract significant interest and investment due to its innovative approach, experienced leadership, and the growing importance of addressing men's health issues.